The Ohio Clinical Trial Collaborative (OCTC)
The Ohio Clinical Trial Collaborative OCTC is developing partnerships with the drug industry to include Biotech and Pharmaceutical industries to perform clinical drug trials phase I-4. The OCTC is a network of Ohio based hospitals led by working groups in areas such as neuro oncology, pediatrics, infectious disease, and neuroscience. The OCTC was launched at the BIO2014 which was attended by 15,000 biotech and pharmaceutical executives in San Diego resulting in numerous leads for potential drug trials.
The OCTC has plans to attend additional biotech and pharmaceuticals shows. The OCTC is looking for additional working groups interested in developing a sell sheet that can then be searched on the World Wide Web and will begin sales and marketing activities to identify opportunities with industry. If there are companies that individuals would like OCTC to target, the group welcomes that feedback.
Review the OCTC working website at: http://ohioclintrials.org.
Contact Joe Peter at 216-702-5314 for more information.
Clinical & Translational Science Collaborative (CTSC)
The CTSC Annual Pilot Program is for researchers to conduct innovative translational research projects focused on the invention, preclinical development and/or first in man studies of novel therapeutic agents, biomedical devices, and diagnostics designed to address unmet clinical needs. Funding is intended to facilitate development of enabling technologies; new therapeutic, diagnostic or outcomes assessment approaches and/or device; novel cross-disciplinary collaborative programs; and promote research in the community.
Research which may create intellectual property is encouraged. If funding would enhance an existing non-federally funded project or enable a proposal to a federal agency for use of CTSC and CCTRP resources, the application would be considered. This pilot has few restrictions and allows for the hiring of personnel. Researchers new to clinical research, clinical research scholars, or experienced researchers who are moving into a new area of research are strongly encouraged to apply.
Available Funds: Up to $50,000 per project for up to one year of support.
Deadline for Letter of Intent: January 15, 2015.
For questions contact:
CTSC Pilot Program Office:
For more information, visit the CTSC website.
Did You Know?
Grant proposals are due in the Office of Research Administration (or Office of Grants & Contracts in SOM) at least 5 working days before the sponsor’s deadline. This allows time for an institutional review and correction of errors or omissions. As soon as you decide to submit a grant, contact your designated ORA or OGC specialist to let him/her know to expect your proposal. All funding proposals are now submitted on-line through the Sparta system.
Office of Research Administration: https://research.case.edu/index.cfm
Office of Grants & Contracts in SOM: http://casemed.case.edu/grantscontracts/
Sparta System: https://sparta.case.edu/.
Department of Defense
The Department of Defense has announced the following new funding opportunities:
Department of the Army - USAMRAA
DoD Orthotics and Prosthetics Outcomes Research Award
U.S. Army Medical Research and Materiel Command Broad Agency Announcement (BAA) for Extramural Medical Research - Dept. of the Army -- USAMRAA — W81XWH-BAA-15-1
Opening date: October 1, 2014
Closing date: September 30, 2015
Pre-Proposals:Applicants are encouraged to submit their Pre-Proposals as early as possible in the fiscal year as funding is based on availability
Invitation to Submit: within 120 days of pre-proposal submission
Full Proposals: submitted within 90 days of the invitation
Notice of Awards: within 180 days of submission
Funding: Budgets are not capped and must reflect the scope of the work. Funding can be requested for up to 5 years.
Programs of interest:
1. Military Infectious Diseases Research
2. Combat Casualty Care Research
3. Military Operational Medicine Research
4. Clinical and Rehabilitative Medicine Research
5. Medical Biological Defense Research
6. Medical Chemical Defense Research
7. Medical Training and Health Information Sciences
8. Radiation Health Effects Research
9. Special Investment Areas
Office of Strategic Initiatives (OSI): CWRU School of Medicine's OSI can work with you to make sure that you meet the current goals and objectives of the USAMRMC.
Contact OSI: Irene Shaland - email@example.com - 216.368.4970.
Limited Submission Reminder: NSF Materials Innovation Platforms (MIP)
Key Deadlines: January 5, 2015, 5:00pm (CWRU Internal Submission Deadline), March 2, 2015, 5:00pm EST.
The Division of Materials Research (DMR) seeks to significantly accelerate advances in materials research and engineering through the rapid discovery of new materials and phenomena by developing a new midscale user facility program - Materials Innovation Platforms (MIP) program. MIPs embrace the paradigm set forth by the Materials Genome Initiative (MGI) which strives to "discover, manufacture, and deploy advanced materials in half the time and at a fraction of the cost." Platforms respond to the increasing complexity of conducting materials research that requires the close collaboration of multidisciplinary teams who have access to cutting edge tools. To accelerate research outcomes, Platforms conduct research through iterative "closed-loop" efforts among the areas of materials synthesis, characterization, theory, and the application of theory through modeling and/or simulation. The in-house research conducted by a MIP is transformational and focuses on a targeted materials grand challenge and/or a technological outcome (e.g., understanding complexity, discovery of new phenomena and materials, etc.) that addresses a national priority.
MIPs push the frontiers in materials research by advancing the capabilities of current state-of-the-art experimental tools through the development of new techniques and the next generation of instrumentation that will lead to understanding and discovering new phenomena as well as the discovery of complex functional material systems. In addition, it is expected that open access to these cutting edge tools will strengthen collaborations among scientists and enable researchers to work in new ways, while fostering new modalities of multidisciplinary education and training. The user facility aspect of a Platform accounts for approximately 50% of the collaborative effort, where a MIP provides access to unique high-quality, state-of-the-art instrumentation and technological services through a staff of experts that are accessible to external researchers and all types of institutions. Due to this convergence of expertise, MIPs will serve as focal points that promote cross-fertilization of ideas between internal and external researchers.
The Platform, the tools and techniques developed, and the resulting new materials are themselves meant to be transformative. The US, once a global leader in materials synthesis, has fallen behind in the science of crystal growth. To rebuild technical strength in this area, the initial MIPs will focus on developing new bulk and thin film crystalline hard materials. The scientific focus of the MIP program is subject to change from competition to competition. MIPs are anticipated to be five year awards totaling $10,000,000 to $25,000,000 for the award period. MIP awards are eligible for a one-time five-year renewal, subsequent to a rigorous and favorable review by NSF. To cover the breadth of this endeavor, it is expected that proposed projects will be directed by a team of at least three Senior Personnel with complementary expertise. Equipment acquisition is expected in the first few years, but yearly budget should not exceed $7.0M.
For more information on this limited submission opportunity, visit the Office of Research Administration website.
If you have news or information that you wish to have included in this
update, please send it via e-mail to Tracy Wilson-Holden at
firstname.lastname@example.org no later than
5 pm on the Monday of the week that the update is to be distributed. If you
know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe
to Case Research News, email your request to Tora Williams at
Please note: At the time of this transmission, all links functioned.
However, Case Research News cannot guarantee that the information will not move or be